Search

everythinglearnresearchcommunity

for

Search:↓

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

Some plant-based treatments may help with ovary function, insulin resistance, and excess male hormones in PCOS, but more research is needed to confirm their safety and effectiveness.

Quercetin may help with PCOS symptoms, but more research is needed.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Sebocytes play a key role in controlling androgen levels in human skin.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

New genes and pathways are important for testosterone production and male sexual development.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

Low prolactin in young women may increase heart and metabolism risks.

New compounds may soon be tested to treat excessive hair growth in women.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Treatment during development affects hormone balance and sexual behavior in male rats.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.